Protein engineering: security implications
暂无分享,去创建一个
[1] Unoda. Convention on the Prohibition of the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and on their Destruction [BWC Convention], U.N. Doc. A/Res/2826; 1015 U.N.T.S. 163; 26 U.S.T. 583; 11 I.L.M. 309 (10 Apr. 1972) , 2001, International Terrorism: Multilateral Conventions (1937-2001).
[2] A. Ménez,et al. Direct expression in E. coli of a functionally active protein A--snake toxin fusion protein. , 1989, Protein engineering.
[3] Protein engineering of diphtheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high-affinity IL-2-receptor-bearing target cells. , 1991, Protein engineering.
[4] P. Marrack,et al. Superantigens and their potential role in human disease. , 1993, Advances in immunology.
[5] J. Tucker. Dilemmas of a Dual-Use Technology: Toxins in Medicine and Warfare , 1994, Politics and the Life Sciences.
[6] N. Arora,et al. Cytotoxic effects of a chimeric protein consisting of tetanus toxin light chain and anthrax toxin lethal factor in non-neuronal cells. , 1994, The Journal of biological chemistry.
[7] C. Roumestand,et al. Scorpion toxins as natural scaffolds for protein engineering. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[8] J. Murphy,et al. Fusion protein toxins based on diphtheria toxin: selective targeting of growth factor receptors of eukaryotic cells. , 2000, Methods in enzymology.
[9] M. McCarthy,et al. Antisense oligodeoxynucleotides as a tool in developmental neuroendocrinology. , 2000, Methods.
[10] J. Madsen,et al. Toxins as weapons of mass destruction. A comparison and contrast with biological-warfare and chemical-warfare agents. , 2001, Clinics in laboratory medicine.
[11] R. Kreitman. Chimeric fusion proteins--Pseudomonas exotoxin-based. , 2001, Current opinion in investigational drugs.
[12] F. Foss. Interleukin‐2 Fusion Toxin: Targeted Therapy for Cutaneous T Cell Lymphoma , 2001, Annals of the New York Academy of Sciences.
[13] K. Aktories,et al. The Binary Clostridium botulinum C2 Toxin as a Protein Delivery System , 2002, The Journal of Biological Chemistry.
[14] R. Sullivan,et al. Biological Toxins: A Bioweapon Threat in the 21st Century , 2002 .
[15] Using Modified Bacterial Toxins To Deliver Vaccine Antigens , 2003 .
[16] New considerations in infectious disease outbreaks: the threat of genetically modified microbes. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] Milton Leitenberg,et al. Assessing The Biological Weapons And Bioterrorism Threat , 2005 .
[18] B. Rich,et al. Bioactive IL7-diphtheria fusion toxin secreted by mammalian cells. , 2005, Protein engineering, design & selection : PEDS.
[19] James B Petro,et al. Biological threat characterization research: a critical component of national biodefense. , 2005, Biosecurity and bioterrorism : biodefense strategy, practice, and science.
[20] P. Millett,et al. The biological and toxin weapons convention. , 2006, Revue scientifique et technique.
[21] Lisa Tabassi,et al. Making Treaties Work: The Convention on the Prohibition of the Development, Production, Stockpiling and Use of Chemical Weapons and on their Destruction (Chemical Weapons Convention) , 2007 .